MTT Cell Proliferation Assay: Principle, Protocol, and Applications

The MTT cell proliferation assay is a widely adopted colorimetric method for quantifying cell viability and metabolic activity in vitro. Based on the enzymatic reduction of the yellow tetrazolium dye MTT into purple formazan crystals by metabolically active cells, this technique offers a sensitive, reproducible, and cost-effective solution for drug screening, cytotoxicity evaluation, and proliferation studies. This article presents the technical principle, sample types, testing workflow, applications, and frequently asked questions related to the MTT assay.

Technical Overview

The MTT assay, first introduced by Tim Mosmann in 1983, remains one of the most established colorimetric methods for measuring cell proliferation and viability. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) is a water-soluble yellow tetrazolium salt that penetrates viable cells, where it is cleaved by NAD(P)H-dependent oxidoreductase enzymes located primarily in the mitochondrial inner membrane, as well as in the cytoplasm and plasma membrane.

Upon reduction, MTT forms insoluble purple formazan crystals that accumulate within healthy cells. Because dead or metabolically inactive cells lack the enzymatic capacity to perform this reduction, the quantity of formazan produced is directly proportional to the number of viable cells. The crystals are subsequently dissolved using a solubilization agent such as dimethyl sulfoxide (DMSO), acidified isopropanol, or a detergent-based solution, and the resulting colored solution is quantified by measuring absorbance at 570 nm using a microplate spectrophotometer, typically with a reference wavelength between 630 nm and 690 nm.

This straightforward readout makes the MTT assay a foundational tool in cell biology, oncology research, pharmacology, and toxicology laboratories worldwide.

Testing Samples

Tumor Cell Lines

Both adherent and suspension cancer cell lines are routinely analyzed using the MTT assay to evaluate proliferation kinetics and sensitivity to therapeutic agents. Common examples include HeLa, MCF-7, A549, HepG2, HCT116, and numerous NCI-60 panel cell lines.

Primary Cells and Normal Cell Lines

Primary cultures such as fibroblasts, endothelial cells, hepatocytes, and peripheral blood mononuclear cells (PBMCs) can be assessed to establish selectivity indices, comparing toxicity toward normal cells versus malignant cells.

Stem Cells

Mesenchymal stem cells, induced pluripotent stem cells, and neural progenitor cells may be tested to characterize self-renewal capacity and responses to differentiation cues or growth factors.

Test Compounds and Formulations

Small-molecule drug candidates, natural product extracts, antibodies, nanoparticles, cosmetic ingredients, and biomaterial extracts are applied to cultured cells to determine their effects on proliferation and survival.

Testing Items

The MTT assay supports a broad range of quantitative endpoints, including:

• Cell viability percentage relative to untreated controls
• Cell proliferation rate over defined time intervals
• Cytotoxicity profiling of test compounds across concentration gradients
• IC50 determination, defined as the concentration inhibiting 50% of cell growth
• Dose-response curve generation and statistical comparison between treatment groups
• Growth factor and cytokine bioactivity quantification
• Combination drug synergy or antagonism evaluation
• Phototoxicity and radiosensitization assessment in paired experimental designs

Testing Methods

A standardized MTT proliferation assay follows a well-defined workflow optimized for 96-well microplate formats:

Cell Seeding

Cells in the logarithmic growth phase are harvested, counted, and seeded into 96-well plates at an optimized density, typically ranging from 1,000 to 10,000 cells per well depending on cell size, doubling time, and incubation duration. Adherent cells are allowed to attach overnight in complete culture medium at 37°C in a humidified incubator with 5% CO2.

Compound Treatment

Test articles are serially diluted and added to designated wells, commonly generating five to eight concentrations spanning at least three logarithmic units. Blank wells containing medium only, untreated control wells, vehicle control wells, and positive control wells (such as a known cytotoxic agent) are established in parallel. Plates are incubated for 24, 48, or 72 hours according to the experimental design.

MTT Incubation

MTT stock solution, typically prepared at 5 mg/mL in sterile phosphate-buffered saline, is added to each well to achieve a final concentration of 0.5 mg/mL. Plates are incubated for 2 to 4 hours under standard culture conditions, during which viable cells convert the dye into formazan crystals.

Formazan Solubilization

Following careful removal of the culture medium, DMSO or another validated solubilization reagent is added to dissolve the purple formazan precipitate. Gentle mixing on an orbital shaker ensures complete and homogeneous dissolution, a critical step for absorbance accuracy.

Absorbance Measurement and Data Analysis

Optical density is recorded at 570 nm with a 630 nm to 690 nm reference correction. After subtracting blank values, cell viability is calculated as the percentage of absorbance relative to the untreated control group. Dose-response curves are fitted using nonlinear regression to derive IC50 values, with results typically presented as the mean plus or minus standard deviation from at least three independent replicate wells.

Quality Control Considerations

Key parameters ensuring reliable results include confirming the linear relationship between cell number and absorbance, maintaining consistent MTT exposure time, avoiding edge effects through plate layout design, and verifying that test compounds do not directly reduce MTT or interfere with absorbance at the measurement wavelength.

Applications

The MTT assay is extensively utilized across academic, pharmaceutical, and industrial research settings:

• High-throughput screening of anticancer drug candidates and natural product libraries
• Preclinical safety and cytotoxicity evaluation of new chemical entities
• Nanomaterial biosafety assessment for biomedical applications
• Cosmetic ingredient efficacy and safety testing as an alternative to animal testing
• Immunomodulatory studies evaluating lymphocyte proliferation in response to mitogens
• Radiosensitizer and chemosensitizer evaluation in cancer research
• Biocompatibility testing of medical device extracts and biomaterials
• Assessment of oxidative stress agents and protective compounds on cell survival

FAQ

What is the fundamental principle of the MTT assay?

The assay relies on the ability of metabolically active cells to reduce the yellow tetrazolium dye MTT into insoluble purple formazan crystals through mitochondrial and cytosolic dehydrogenase enzymes. The absorbance of the dissolved formazan product correlates directly with the number of viable cells.

How long does a typical MTT assay take?

Following cell seeding and treatment, the MTT incubation step requires approximately 2 to 4 hours, and solubilization with absorbance reading generally takes an additional 30 to 60 minutes. A complete experiment, including cell culture and treatment, usually spans 2 to 4 days.

What are the limitations of the MTT assay?

Because formazan crystals must be dissolved before measurement, the assay is terminal and cannot track the same cells over time. Additionally, compounds that alter metabolic enzyme activity without affecting cell number, or those with intrinsic color or reducing properties, may introduce artifacts requiring appropriate controls.

How does the MTT assay compare with alternative methods?

Alternative tetrazolium reagents such as MTS, XTT, WST-1, and CCK-8 produce water-soluble formazan, eliminating the solubilization step. Resazurin-based assays offer fluorescence readouts, while ATP-based luminescence assays provide higher sensitivity. MTT remains widely favored for its low cost, robustness, and extensive historical reference data.

What controls are essential for accurate results?

Each experiment should include blank wells without cells, untreated cell controls, vehicle controls matching the solvent concentration of treated wells, and ideally a positive cytotoxicity control to confirm assay responsiveness.